AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 inter alia to consider and approve We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a Meeting of the Board of Directors of the Company will be held on Tuesday May 28 2019 to consider inter alia the Audited Financial Results of the Company for the fourth quarter and year ended March 31 2019.
Further to our letter dated April 3 2019 informing the closure of Trading Window of the Company from April 4 2019 until 48 hours from the date of declaration of the Audited Financial Results of the Company for the fourth quarter and year ended March 31 2019 we would like to inform you that the Trading Window will be closed up to May 30 2019 and shall be re-opened on May 31 2019.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
